Table 1.
Sociodemographic characteristics and odds ratios for use of any psychotropic medication in the previous 12 months
| Sociodemographic variable (n) | Sample (%) | Any psychotropic | ||
|---|---|---|---|---|
| N | % | ORa (95% CI) | ||
| Total (4340) | 100 | 733 | 14.9 | – |
| One psychotropic medication only | – | 419 | 8.9 | – |
| More than one psychotropic medication | – | 314 | 6.0 | – |
| Gender | ||||
| Male (1899) | 48.0 | 229 | 10.2 | Reference |
| Female (2441) | 52.0 | 504 | 19.4 | 1.4 (1.0–1.9) |
| χ12 | 72.2*** | |||
| Age (years) | ||||
| 18–34 (1127) | 30.6 | 134 | 10.5 | Reference |
| 35–49 (1297) | 30.6 | 210 | 14.3 | 1.4 (0.9–2.2) |
| 50–64 (1064) | 21.2 | 251 | 21.7 | 2.5 (1.5–4.0)*** |
| 65+ (852) | 17.7 | 138 | 15.7 | 1.4 (0.7–2.5) |
| χ32 | 54.9** | |||
| Marital status | ||||
| Married (2553) | 59.2 | 361 | 13.1 | Reference |
| Never married (1024) | 26.8 | 152 | 12.3 | 1.1 (0.7–1.7) |
| SWD (763) | 14.0 | 220 | 27.9 | 1.8 (1.2–2.6)** |
| χ22 | 94.4*** | |||
| Incomeb | ||||
| Low (470) | 24.7 | 114 | 17.2 | Reference |
| Low-average (494) | 25.4 | 116 | 16.6 | 1.0 (0.6–1.4) |
| High-average (572) | 28.3 | 110 | 14.9 | 0.9 (0.6–1.3) |
| High (450) | 21.6 | 63 | 13.0 | 0.8 (0.5–1.5) |
| χ32 | 3.8 | |||
| Education | ||||
| Primary (316) | 6.6 | 61 | 20.9 | Reference |
| Secondary (2450) | 56.5 | 437 | 15.4 | 0.7 (0.3–1.3) |
| A-Level (1048) | 24.4 | 149 | 12.9 | 0.6 (0.3–1.3) |
| Tertiary (526) | 12.5 | 86 | 13.6 | 0.6 (0.2–1.3) |
| χ32 | 12.9* | |||
| Traumab | ||||
| None (699) | 39.4 | 98 | 9.3 | Reference |
| Non-conflict-related only (470) | 21.7 | 111 | 19.3 | 1.6 (1.0–2.4)* |
| Conflict-related (817) | 39.0 | 194 | 19.6 | 1.7 (1.2–2.4)** |
| χ22 | 37.6*** | |||
OR, odds ratios; CI, confidence interval; SWD, separated/widowed/divorced.
Raw numbers and weighted proportions reported throughout.
*p < 0.05; **p < 0.01; ***p < 0.001.
aAdjusted odds ratios (controlling for all other variables in the model and any 12-month disorder).
bOnly assessed in participants who completed part 2 of the interview.